Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Extending the Duration of the Neurology Clerkship – Does it Matter?
Research Methodology, Education, and History
S23 - Research Methodology and Education (4:08 PM-4:16 PM)
002

The neurology clerkship at our institution is required and is four weeks in duration. However, the optimal length to provide sufficient exposure to medical students remains unknown. We investigated whether an additional week of neurology exposure would improve students’ neurology clerkship experience and stimulate interest in the discipline.

To evaluate if extending the neurology clerkship duration positively impacts students’ perception of neurology.

Third-year students rotating through their core four-week (n=94) or five-week (n=94) neurology clerkship in two consecutive years took part in the study. Participants completed surveys on their perceptions of neurology and their overall experience during the clerkship after concluding their rotation. Their exam scores and grades in neurology and the number of the students applying to the national neurology resident match were also collected.

Medical students’ interest in pursuing neurology residency was significantly higher in the 5-week group (20.21%) compared to the 4-week group (9.57%) (p=0.04). This led to an increase in adult or pediatric neurology match applications (11.70%) in the 5-week group compared to the 4-week group (3.19%) (p=0.03). Moreover, neurology residents were perceived as better role models in terms of bedside manner and professionalism (90.43% vs. 77.66%; p=0.02).

An increase in the length of the neurology clerkship stimulated more interest in neurology among the medical students. In addition, the students reported perceiving the residents as role models, which likely positively impacted their overall impression of the neurology clerkship experience and highlights the importance of residents in medical education.

Authors/Disclosures
Zafer Keser, MD (Mayo Clinic)
PRESENTER
Dr. Keser has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Practice Update.
Jorge E. Patino Murillas, MD (The University of Texas Health Science Center at Houston McGovern Medical School) Dr. Patino Murillas has nothing to disclose.
Yvo A. Rodriguez-Linares, MD (UTHealth McGovern Medical School Neurology Department) Dr. Rodriguez-Linares has nothing to disclose.
Rachel C. Beck Mrs. Beck has nothing to disclose.
Luke Kupcha, MD (UNC hospital) Mr. Kupcha has nothing to disclose.
Louise D. McCullough, MD, PhD (McGovern Medical School, UTHealth) The institution of Dr. McCullough has received research support from NIH. The institution of Dr. McCullough has received research support from American Heart Association.
Stefano Sandrone, PhD Dr. Sandrone has nothing to disclose.
Erin Furr-Stimming, MD, FAAN (University of Texas Health Science Center-Houston) Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Michael J. Fox Foundation. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. The institution of Dr. Furr-Stimming has received research support from Huntington's Disease Society of America. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from Sage Therapeutics. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care.